Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients [9]

AIDS

Volumn 12, Issue 18, 1998, Pages 2511-2513

  Revankar, S G ^a   Sanche, S E ^a   Dib, O P ^a   Caceres, M ^a   Patterson, T F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; FLUCONAZOLE;

CANDIDA ALBICANS; CANDIDIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; OROPHARYNX; PRIORITY JOURNAL; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 0032564520     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)